XARlabs Closes $2.3 Million in Seed Funding
Adds Global Technology and Business Leaders Jacqui Rock and Eric Johnson to its Board LONDON, Feb. 10, 2025 /PRNewswire/ --...
Month: February 2025
SandboxAQ Expands Alliance with Deloitte to Offer AI Simulation Software Solutions
Alliance to add focus for Large Quantitative Models (LQMs) which are the new frontier in AI with applications in biopharma,...
Workday Named Best in KLAS for ERP (Large) for the Eighth Consecutive Year
PLEASANTON, Calif., Feb. 10, 2025 /PRNewswire/ -- Workday, Inc. (NASDAQ: WDAY), a leading provider of solutions to help organizations manage their people...
ETQ Reaches Significant Milestones in Final Quarter of 2024, Reinforces its Leadership in Advanced Quality Management Systems for Manufacturers
Key Milestones Include Launch of ETQ Reliance Predictive Analytics Solution, Expanding Client Base, Annual Customer Conference and Innovation Awards BURLINGTON,...
Aligner Experts Expands to Three Locations in Chicago, IL
CHICAGO, Feb. 10, 2025 /PRNewswire/ -- Aligner Experts is proud to announce the opening of three new locations in Chicago,...
Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors
Calgary, Alberta--(Newsfile Corp. - February 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
GE HealthCare management to present at upcoming investor conference
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at Citi’s 2025 Medtech and...
GE HealthCare management to present at upcoming investor conference
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at Citi’s 2025 Medtech and...
GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment
UNC Health to Become the First Health System to Collaborate with GeneDx Through Aura, Epic’s Specialty Diagnostic SuiteGAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx...
GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment
UNC Health to Become the First Health System to Collaborate with GeneDx Through Aura, Epic’s Specialty Diagnostic SuiteGAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx...
Aurion Biotech Appoints Donald Munoz as Chief Financial Officer
Experienced Healthcare Executive to Lead Finance OrganizationSEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (Aurion), whose mission is to...
SoldierStrong Joins Forces With Patriot Mobile to Assist Military Veterans in Taking Their Next Steps Forward
STAMFORD, Conn., Feb. 10, 2025 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit dedicated to providing revolutionary medical technology to U.S....
Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition
HOUSTON, TEXAS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader...
Capricor Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based...
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model...
BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress
RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will...
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial
No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial Achieve Reiterates Planned Cytisinicline NDA Submission in Q2...
Oncocyte Prices $29.1 Million Equity Offering
Proceeds Expected to Fund Transplant Assay Through FDA IVD Clearance and Commercial LaunchStrategic Partner Bio-Rad Invests, Boosts Support for Trial...
Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy
Company highlights key milestones achieved in 2024, growing revenues and progress towards U.S. expansion in 2025NEW YORK, Feb. 10, 2025...
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
February 10, 2025 Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for...